| Literature DB >> 35832584 |
Yaqiong He1, Peng Liu1, Leyun Xie2, Saizhen Zeng2, Huashan Lin3, Bing Zhang2, Jianbin Liu1.
Abstract
Objective: To construct and validate a predictive model for risk factors in children with severe adenoviral pneumonia based on chest low-dose CT imaging and clinical features.Entities:
Keywords: adenovirus pneumonia; children; low-dose CT; nomogram; prediction model
Year: 2022 PMID: 35832584 PMCID: PMC9271770 DOI: 10.3389/fped.2022.874822
Source DB: PubMed Journal: Front Pediatr ISSN: 2296-2360 Impact factor: 3.569
FIGURE 1Workflow of the study. Workflow can be divided into three parts:patient selection, feature extraction, and model construction.
Demographic, clinical and chest CT findings of patients with adenovirus pneumonia included in the study.
| Characteristics | Total | MAP group | SAP group | Training Cohort | Validation Cohort | ||
|
| |||||||
| Gender | <0.001 | 0.919 | |||||
| Male | 149 | 117 | 32 | 105 | 44 | ||
| Female | 28 | 8 | 20 | 20 | 8 | ||
| Age (month) | 177 | 36 (18.1, 55.3) | 12 (12, 36) | <0.001 | 36 (12, 48) | 24 (12, 48) | 0.908 |
| Weight | 177 | 15 (11.0, 18.1) | 12 (9.2, 14.4) | <0.001 | 14 (10.5, 16.7) | 13 (10.7, 17.9) | 0.914 |
|
| |||||||
| Fever (°C) | 177 | 37.1 (36.6, 38.3) | 37.9 (37.0, 38.7) | <0.001 | 37.4 (36.8, 38.4) | 37.2 (36.6, 38.5) | 0.715 |
| Fever course (days) | 177 | 5 (4, 7) | 5 (4, 7) | 0.988 | 5 (4, 7) | 5 (4, 6) | 0.895 |
|
| |||||||
| WBC (×10 9/L) | 177 | 7.58 (5.17, 10.31) | 6.32 (4.8, 9.6) | 0.169 | 6.67 (4.94, 9.99) | 7.54 (5.38, 10.06) | 0.629 |
| NEU | 177 | 3.34 (2.33, 5.38) | 4.57 (3.17, 8.01) | 0.005 | 3.55 (2.63, 6.57) | 3.62 (2.37, 5.91) | 0.842 |
| Lymphocyte | 177 | 2.73 (1.83, 3.84) | 1.98 (1.33, 4.54) | 0.168 | 2.68 (1.69, 4.14) | 2.34 (1.66, 3.53) | 0.66 |
| L/N ratio | 177 | 0.66 (0.48, 1.26) | 0.48 (0.35, 0.84) | 0.002 | 0.65 (0.36, 1.05) | 0.66 (0.47, 1.17) | 0.591 |
| L/W ratio | 177 | 0.36 (0.29, 0.50) | 0.32 (0.25, 0.51) | 0.36 | 0.36 (0.27, 0.51) | 0.36 (0.29, 0.49) | 0.929 |
| CRP | 177 | 12.8 (4.3, 28.3) | 12.5 (4.1, 18.9) | 0.3 | 12.60 (4.33, 24.14) | 15.70 (4.06, 33.81) | 0.213 |
| LDH | 177 | 343 (285, 425) | 629 (423, 989) | <0.001 | 393 (306, 605) | 34 (298, 509) | 0.187 |
| ALT | 177 | 15.7 (11.8, 21.3) | 22.1 (16.5, 32.0) | <0.001 | 16.9 (12.8, 25.2) | 18.1 (11.7, 24.0) | 0.766 |
| AST | 177 | 40.9 (31.1, 58.1) | 66.2 (47.3, 102.6) | <0.001 | 46.9 (34.9, 69.8) | 43.6 (32.5, 63.9) | 0.386 |
| CK-MB | 177 | 24 (18, 32) | 38 (23, 53) | <0.001 | 28 (20, 41) | 23.5 (17.5, 34.7) | 0.100 |
| ADV DNA level | 177 | 5.76 (3.96, 7.26) | 6.62 (5.66, 7.58) | 0.017 | 6.31 (4.65, 7.40) | 5.58 (3.92, 7.07) | 0.07 |
|
| |||||||
| Air bronchogram | 0.003 | 0.193 | |||||
| Positive | 78 | 46 | 32 | 59 | 19 | ||
| Negative | 99 | 79 | 20 | 66 | 33 | ||
| Pulmonary emphysema | <0.001 | 0.190 | |||||
| Positive | 85 | 48 | 37 | 64 | 21 | ||
| Negative | 92 | 77 | 15 | 61 | 31 | ||
| Mosaic sign | 0.462 | 0.978 | |||||
| Positive | 44 | 33 | 11 | 31 | 13 | ||
| Negative | 133 | 92 | 41 | 94 | 39 | ||
| Bronchial wall thicken | 0.024 | 0.005 | |||||
| Positive | 150 | 101 | 49 | 112 | 38 | ||
| Negative | 27 | 24 | 3 | 13 | 14 | ||
| Bronchiectasis | 0.608 | 0.905 | |||||
| Positive | 8 | 5 | 3 | 5 | 3 | ||
| Negative | 169 | 120 | 49 | 120 | 49 | ||
| Pleural effusion | 0.009 | 0.987 | |||||
| Positive | 12 | 4 | 8 | 9 | 3 | ||
| Negative | 165 | 121 | 44 | 116 | 49 | ||
| Consolidation score | 177 | 0 (0, 1) | 3 (1, 4) | <0.001 | 1.00 (0.00, 2.00) | 0.00 (0.00, 2.00) | 0.13 |
| Lobular inflammation score | 177 | 3 (1, 5) | 4 (2, 6) | 0.014 | 3.00 (1.00, 5.00) | 2.00 (1.00, 4.00) | 0.051 |
Categorical variables are presented as number of patients and data in parentheses are percentages; continuous variables are showed as median (lower quartile, upper quartile).
Statistical analysis was performed with Wilcoxon Test or Fisher exact test.
The symbol * for P < 0.05 suggests a significant difference.
MAP, mild adenovirus pneumonia; SAP, severe adenovirus pneumonia; WBC, white blood cell; NEU, neutrophile; CRP, C-reactive protein; LDH, lactate dehydrogenase; ALT, alanine transaminase; AST, aspartate transaminase; CK-MB, creatine kinase-MB.
FIGURE 2Chest CT imaging findings of adenovirus pneumonia. (A) Right upper lung consolidation with bronchial inflation sign; (B) left emphysema; (C) double lung mosaic sign; (D) right lower lung bronchial wall thickening and surrounding lobule inflammation; (E) right Middle lung bronchiectasis; (F) a small amount of pleural effusion on the right.
Multivariable logistic regression for nomogram construction.
| Characteristics | Odd ratio | 95% CI | |
| Gender | 0.21 | 0.05–0.83 | 0.026 |
| LDH | 1.00 | 1.00–1.00 | 0.013 |
| Pulmonary emphysema | 8.28 | 2.23–30.75 | 0.001 |
| Consolidation scores | 1.53 | 1.08–2.17 | 0.017 |
| Lobular inflammation scores | 1.14 | 0.97–1.34 | 0.001 |
The odd ratio was 0.21 means that male showed lower likelihood of severe pneumonia.
The Odds Ratio was 8.28 means that patients with pulmonary emphysema showed higher likelihood of severe pneumonia.
*P value < 0.05, which showed significance.
FIGURE 3Nomogram. To draw an upward vertical line to the “Points” bar to calculate points. Based on the sum, draw a downward vertical line from the “Total Points” line to calculate the probability of classification of adenoviral pneumonia patient. Male was denoted as 1, and female as 0.
Accuracy and predictive value between three models.
| AUC | 95%CI | Accuracy | Sensitivity | Specificity | PPV | NPV | |
|
| |||||||
| Clinic model | 0.85 | 0.77–0.94 | 0.80 | 0.81 | 0.79 | 0.63 | 0.91 |
| Imaging model | 0.83 | 0.75–0.91 | 0.76 | 0.78 | 0.75 | 0.59 | 0.89 |
| Combined model | 0.91 | 0.85–0.97 | 0.86 | 0.84 | 0.87 | 0.74 | 0.93 |
|
| |||||||
| Clinic model | 0.77 | 0.64–0.91 | 0.69 | 0.47 | 0.78 | 0.47 | 0.78 |
| Imaging model | 0.83 | 0.71–0.94 | 0.73 | 0.53 | 0.81 | 0.53 | 0.81 |
| Combined model | 0.85 | 0.73–0.96 | 0.77 | 0.57 | 0.90 | 0.80 | 0.76 |
AUC area under the curve; CI confidence interval; NPV negative-predictive value; PPV positive-predictive value.
FIGURE 4ROC curve for the three model in the training cohort with an AUC of 0.91, 0.83, and 0.85, respectively (A). ROC curve for the three model in the validation cohort with an AUC of 0.85, 0.83, and 0.77, respectively (B).
FIGURE 5Calibration curve of the Nomogram model in the training cohort (A). Calibration curve of the Nomogram model in the validation cohort (B).
FIGURE 6Decision curve analysis (DCA) for the Nomogram model in validation cohort. Compared to other models, the combined Nomogram model, showing the highest area under the curve, is the optimal decision making for maximal net benefit in prediction of severe adenoviral pneumonia.